This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Biontech Se, Tron—translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh, Biontech Rna Pharmaceuticals Gbmh. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 74 
2 out of 16 
1 out of 1 Years Active: 2021-2024
Title: The Innovative Mind of Sebastian Boegel
Introduction
Sebastian Boegel, an accomplished inventor based in Obermoschel, Germany, has made significant strides in the field of immunotherapy through his innovative methods and solutions. With a total of three patents to his name, Boegel's work primarily focuses on predicting the usefulness of proteins and protein fragments for personalized cancer vaccines.
Latest Patents
Among his latest patents, Boegel has developed methods that predict the immunogenicity of peptides and polypeptides. One key invention relates to predicting T cell epitopes, particularly tumor-associated neoantigens. This invention plays a critical role in personalizing cancer vaccines by identifying which peptides can induce an immune response specific to a patient's tumor, thereby enhancing the efficacy of immunotherapy.
Another notable patent focuses on predicting whether specific tumor-associated antigens or neoepitopes are immunogenic. This invention aims to facilitate the development of vaccines tailored to individual patients, making strides toward more effective cancer treatments through personalized medicine.
Career Highlights
Sebastian Boegel has contributed his expertise to prominent companies such as BioNTech SE and the Translational Oncology Institute at the University Medical Center of Johannes Gutenberg University Mainz. His work at these institutions has allowed him to push the boundaries of cancer research and treatment, particularly in the development of immunotherapeutic approaches.
Collaborations
Throughout his career, Boegel has had the privilege of collaborating with esteemed professionals in his field, including Ugur Sahin and Arbel David Tadmor. These partnerships have contributed to the advancement of his projects and the successful implementation of his innovative inventions.
Conclusion
Sebastian Boegel is an exemplary inventor whose contributions to immunotherapy and personalized cancer treatment are noteworthy. His commitment to innovation and collaboration continues to pave the way for new and effective therapeutic strategies in the fight against cancer. As he develops further methodologies and insights, the potential for transformative advances in healthcare remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile